Influence of lung volume on collateral resistance during methacholine-induced bronchospasm. 1994

M C Coté, and F Sériès, and M Laviolette, and F Laberge, and L Atton, and Y Cormier
Unité de Recherche, Centre de Pneumologie de l'Hôpital Laval, Université Laval, Québec, Canada.

We tested the hypothesis that lung inflation in response to a bronchospasm could be beneficial by maintaining the lung collateral channels open. Six mild asthmatics were studied on 2 separate days. The first day we determined the methacholine dose response and measured collateral resistance (Rcoll) before and during the metacholine-induced bronchospasm and the effects of decreasing lung volumes on Rcoll. The lung volume changes were induced by applying progressively increasing positive extrathoracic pressures (PEP). The second day we measured the changes in end-expiratory lung volume (EELV) resulting from the inhaled methacholine and from the applied positive extrathoracic pressure. With the inhalation of methacholine, the FEV1 decrease ranged from 26-43% of the baseline values while Rcoll increased significantly in only three of the six subjects. EELV remained unchanged in one subject and increased by 1408, 990, 260, and 44 ml in four others. It was not measured in one subject. Decreasing EELV by PEP increased Rcoll in all subjects. By extrapolation of the lung volume-Rcoll relationship, we calculated that Rcoll would have increased by 18,227%, 6843%, 994%, 140%, and 128% if EELV had not increased in the five subjects in whom delta EELV was measured. We conclude that an increase in EELV in response to an induced bronchospasm helps maintain open and functional collateral pathways despite the bronchoconstriction.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D001986 Bronchial Spasm Spasmodic contraction of the smooth muscle of the bronchi. Bronchospasm,Bronchial Spasms,Bronchospasms,Spasm, Bronchial,Spasms, Bronchial
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000403 Airway Resistance Physiologically, the opposition to flow of air caused by the forces of friction. As a part of pulmonary function testing, it is the ratio of driving pressure to the rate of air flow. Airway Resistances,Resistance, Airway,Resistances, Airway
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D016210 Methacholine Chloride A quaternary ammonium parasympathomimetic agent with the muscarinic actions of ACETYLCHOLINE. It is hydrolyzed by ACETYLCHOLINESTERASE at a considerably slower rate than ACETYLCHOLINE and is more resistant to hydrolysis by nonspecific CHOLINESTERASES so that its actions are more prolonged. It is used as a parasympathomimetic bronchoconstrictor agent and as a diagnostic aid for bronchial asthma. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1116) Methacholine,2-(Acetyloxy)-N,N,N-trimethyl-1-propanaminium Chloride,Acetyl-2-methylcholine Chloride,Acetyl-beta-methacholine Chloride,Acetyl-beta-methylcholine,Mecholine,Mecholyl,Provocholine,Provokit,Acetyl 2 methylcholine Chloride,Acetyl beta methacholine Chloride,Acetyl beta methylcholine,Chloride, Methacholine

Related Publications

M C Coté, and F Sériès, and M Laviolette, and F Laberge, and L Atton, and Y Cormier
February 1991, Respiration physiology,
M C Coté, and F Sériès, and M Laviolette, and F Laberge, and L Atton, and Y Cormier
January 1993, Lung,
M C Coté, and F Sériès, and M Laviolette, and F Laberge, and L Atton, and Y Cormier
October 1986, The Journal of allergy and clinical immunology,
M C Coté, and F Sériès, and M Laviolette, and F Laberge, and L Atton, and Y Cormier
July 1992, Respiration physiology,
M C Coté, and F Sériès, and M Laviolette, and F Laberge, and L Atton, and Y Cormier
November 1986, Allergy,
M C Coté, and F Sériès, and M Laviolette, and F Laberge, and L Atton, and Y Cormier
July 1989, The Journal of allergy and clinical immunology,
M C Coté, and F Sériès, and M Laviolette, and F Laberge, and L Atton, and Y Cormier
January 2005, European review for medical and pharmacological sciences,
M C Coté, and F Sériès, and M Laviolette, and F Laberge, and L Atton, and Y Cormier
January 1988, Journal of applied physiology (Bethesda, Md. : 1985),
M C Coté, and F Sériès, and M Laviolette, and F Laberge, and L Atton, and Y Cormier
January 1988, European journal of clinical pharmacology,
M C Coté, and F Sériès, and M Laviolette, and F Laberge, and L Atton, and Y Cormier
April 1990, Respiration physiology,
Copied contents to your clipboard!